Until now, there has been no wound dressing that simultaneously allowed the wound bed to remain moist while preventing it from becoming too wet.
That technological challenge has now been met by the introduction of TheraBond 3D®Antimicrobial Barrier Systems. Choice Theraputics’ patented and proprietary 3D Spacer™ Technology transfers excess fluid and exudate (cellular debris) away from the wound into an inexpensive, easily replaced outer dressing.
For millions of patients with venous leg ulcers, diabetic foot ulcers, burns and other wounds, this can mean faster healing and less suffering. For thousands of hospitals and long-term care centers, and hundreds of thousands of patients at home, this can mean less expense.
Choice Therapeutics’ commitment is to continue to bring technology to bear on the unmet clinical and economic needs of wound care. And, with a management team that has built successful companies before, this is a promise coming from dedicated people who know how to do it.